Sign Up for Our E-Newsletter

In The News

Colon Health Alert: FDA Approves New Screening Test Epi proColon

Posted on April 19, 2016

Colon Health Alert_square

On April 13, 2016, Epigenomics announced that the FDA approved Epi proColon, the first and only blood-based colorectal cancer screening test. This test has the potential to increase participation rates in colorectal cancer screening by providing another option to get checked.

Read more

Study Shows the Benefit of FIT for People in Their 40s

Posted on April 6, 2016

Research Study

As the number of colorectal cancer diagnoses in people under 50 continues to increase, our community is vigilantly looking at ways to combat this alarming trend. A new study, which looked at the accuracy and efficacy of the fecal occult blood tests (FIT), may be the key to getting this population screened.

Unlike a traditional colonoscopy, which can be expensive, requires dietary restrictions and must be done by a healthcare professional, a FIT can be done right in your own home. Even better, it requires no prep and is fairly inexpensive.

This recent study, “Extending Colorectal Cancer Screening to Persons Aged 40 to 49 Years With Immunochemical Fecal Occult Blood Test: A Prospective Cohort Study of 513,283 Individuals,” followed more than 513,000 individuals who had FIT for 14 years; they found one in seven cases of colorectal cancer in people over 40 occurred in the 40 to 49 age group.

Read more

What is Charity Care?

Posted on March 7, 2016


Medical debt is a growing problem in America. I see it every day in my work as a certified patient navigator and patient advocate here at the Colon Cancer Alliance. Almost 60% of calls to our Helpline have to do with financial need.

As treatments get more specialized and personalized, costs will continue to rise. This financial toxicity is just as dangerous to patients as chemotherapy side effects like neuropathy, rashes, etc. Medical debt is now the leading cause of bankruptcy in America.

One solution to this problem is charity care. Read more

An Important Question to Ask Before Starting 5-FU: Am I DPD Deficient?

Posted on February 9, 2016


5-FU (5Fluorouracil) is one of the most common chemotherapies on the market. It is often used to treat cancers of the breast, stomach, pancreas, colon, rectum, head and neck and is given through an IV or infusion. Approved in 1950, it has been the primary treatment for colorectal cancer for more than 60 years.

Read more

CDX2: A Promising New Marker for Stage II & III

Posted on February 9, 2016


In a study published last month in the New England Journal of Medicine, researchers identified a new marker for recurrence in stage II and stage III colon cancer. We sat down with Dr. Laura Porter to breakdown this new marker, the study, and what this news could mean for you.

Read more